ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.

Masoud Nasri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.